ABBVIE INC. Stock Performance
as on August 4, 2026 at 1:11 am IST
Day's Low
Day's High
$244.88$256.00
0.25%
Downside
4.28%
Upside

52 Week's Low
52 Week's High
$190.75$267.47
22.30%
Downside
8.95%
Upside

ABBVIE INC. share price movements today
- Previous Close
- $250.94
- Open
- $252.54
- Volume
- 617.2K
- Day's Low - High
- $244.88 - $256.00
- 52 Week Low - High
- $190.75 - $267.47
ABBVIE INC. Historical Returns
- 1 Month Return
- -3.88 %
- 3 Month Return
- + 21.46 %
- 1 Year Return
- + 28.54 %
- 3 Year Return
- + 68.36 %
- 5 Year Return
- + 115.86 %
ABBVIE INC. Stock Fundamentals & Key Indicators
Check ABBVIE INC. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$443.4B
EPS (TTM)
14.0865
Dividend Yield
1.31%
Quarterly Earnings Growth YOY
2.90%
PE Ratio (TTM)
70.89
Industry PE ratio
23.38125
PEG Ratio
0.4131
EBITDA
30.8B
Revenue (TTM)
64.4B
Profit Margin
9.80%
Return On Equity TTM
62.25%
ABBVIE INC. Stock Valuation
Track how ABBVIE INC. P/E has moved over time to understand its valuation trends.
ABBVIE INC. in the last 5 years
Lowest (9.28x)
September 30, 2021
Industry (23.38x)
August 3, 2026
Today (70.89x)
August 3, 2026
Highest (22.78x)
December 31, 2025
Today’s Price to Earnings Ratio: 70.89x
ABBVIE INC. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of ABBVIE INC. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $443.4B | 115.86% | 70.89 | 9.80% | 1.31% | |
| BUY | $1.0T | 348.78% | 40.81 | 34.99% | 0.54% | |
| BUY | $263.1B | 194.21% | 25.4 | 17.02% | 1.8900000000000001% | |
| BUY | $617.8B | 47% | 29.77 | 21.48% | 2.0500000000000003% | |
| BUY | $307.2B | 70.4% | 36.68 | 13.59% | 2.53% |
Stock Returns calculator for ABBVIE INC. Stock including INR - Dollar returns
The ABBVIE INC. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
ABBVIE INC. investment value today
Current value as on today
₹1,36,735
Returns
₹36,735
(+36.73%)
Returns from ABBVIE INC. Stock
₹25,756 (+25.76%)
Dollar Impact
₹10,979 (+10.98%)
Analyst Recommendation on ABBVIE INC. Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for ABBVIE INC.. Average target price of $270.39
ABBVIE INC. Share Price Target
Get share price movements and forecasts by analysts on ABBVIE INC..
What analysts predicted
9.21%UPSIDE
Target Price
$270.39
Current Price
$245.5
Analyzed by
35 Analysts
Target
$270.39
ABBVIE INC. target price $270.39, a slight upside of 9.21% compared to current price of $245.5. According to 35 analysts rating.
Indian Investors' Interest in ABBVIE INC. Stock
Investment in ABBVIE INC. Shares on INDmoney has dropped by -27.58% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for ABBVIE INC. Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
ABBVIE INC. Quarterly Profit & Loss
All numbers in Millions USD
ABBVIE INC. Annual Profit & Loss
All numbers in Millions USD
ABBVIE INC. Quarterly Cash Flow
All numbers in Millions USD
ABBVIE INC. Annual Cash Flow
All numbers in Millions USD
ABBVIE INC. News & Key Events

Today's Timeline - 31 July
Fri, 07:46 PM
-AbbVie shares fall 2.01% after guidance cut despite strong Q2 earnings beat.
Fri, 08:33 PM
-AbbVie trims full-year EPS guidance due to Apogee acquisition, impacting stock sentiment.
Fri, 08:34 PM
-AbbVie raises full-year revenue outlook by $300 million despite EPS guidance cut due to Apogee acquisition.

Today's Timeline - 31 July
Fri, 10:20 PM
-AbbVie reports Q2 2026 earnings, exceeding expectations with strong growth in immunology and neuroscience portfolios.
Insights on ABBVIE INC.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich

AbbVie Inc. has shown positive revenue growth over the last two quarters. In the most recent quarter, the revenue increased from $15.00 billion to $16.99 billion, reflecting an average growth rate of 11.7% per quarter.
POSITIVE IMPACTProfit Spike

AbbVie Inc. has shown strong profit growth over the last two quarters. In the most recent quarter, the company's net profit increased significantly from $699 million to $3.61 billion. This represents an average growth rate of 80.7% per quarter.
POSITIVE IMPACTPrice Rise

In the last 3 months, ABBV stock has moved up by 21.5%
NO EFFECTAgainst Peers

In the last 3 years, Eli Lilly & Co. has given 143.5% return, outperforming this stock by 75.1%
NO EFFECTAgainst Peers

In the last 1 year, AstraZeneca PLC has given 129.4% return, outperforming this stock by 100.9%
About ABBVIE INC.
| Organisation | ABBVIE INC. |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of ABBVIE INC.
Name | Title |
|---|---|
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Dr. Roopal B. Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer |
Mr. Scott T. Reents | Executive VP & CFO |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Linda Ray | Senior VP & Chief Information Officer |
FAQs
What is ABBVIE INC. share price today?
ABBVIE INC. share price today is $245.50 as on . ABBVIE INC. share today touched a day high of $256.00 and a low of $244.88.
What is the 52 week high and 52 week low for ABBVIE INC. share?
ABBVIE INC. share touched a 52 week high of $267.47 on and a 52 week low of $190.75 on . ABBVIE INC. stock price today i.e. is trending at $245.50,which is 8.21% down from its 52 week high and 28.70% up from its 52 week low.
What is ABBVIE INC.'s market capitalisation today?
ABBVIE INC. market capitalisation is $0.44T as on .
How to invest in ABBVIE INC. Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for ABBVIE INC. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ABBVIE INC. Shares that will get you 0.0061 shares as per ABBVIE INC. share price of $245.50 per share as on August 3, 2026 at 7:41 pm IST.
What is the minimum amount required to buy ABBVIE INC. Stock (ABBV) from India?
Indian investors can start investing in ABBVIE INC. (ABBV) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in ABBVIE INC. stock (as per the Rupee-Dollar exchange rate as on ).
Based on ABBVIE INC. share’s latest price of $245.50 as on August 3, 2026 at 7:41 pm IST, you will get 0.0407 shares of ABBVIE INC.. Learn more about
fractional shares .
What are the returns that ABBVIE INC. has given to Indian investors in the last 5 years?
ABBVIE INC. stock has given 115.86% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?